May 21, 2020
Healthcare workers to participate in chloroquine study
Editor's Note
An international study will include more than 30,000 front-line healthcare workers to assess whether chloroquine can prevent COVID-19 or decrease its severity.
Washington University School of Medicine in St Louis is the clinical coordinating center for the study.
Healthcare workers will be divided randomly into four groups. Three groups will receive chloroquine at various doses, and the fourth group will receive a placebo.
The study will last 5 months.
Free Daily News
- AI outperforms experts in ovarian cancer ultrasound detection
- AI shows promise for addressing nursing workforce challenges
- Union nurses rally for greater staff, patient protection amid AI rollout
- OR Business Management Conference 2025: Groundbreaking opportunity for ASC leaders
- AAAHC earns CMS Medicare deemed status renewal, ensuring quality, safety in ASCs
- Trends, benchmarks, strategic insights from 2024 ASC activity
- Nurses top Gallup’s most trusted professions list as other healthcare roles decline
- Study: Adjusting Caprini score may improve perioperative VTE risk prediction for Blacks, Latinos
- HIPAA security standard update sparks debate over cost, feasibility, patient safety
- Wildfire smoke poses long-term health threats
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement